Vaughan Nelson Investment Management, L.P. Charles River Laboratories International, Inc. Transaction History

Vaughan Nelson Investment Management, L.P.

$11.2 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Jan 13, 2022	SELL	$351.38 - $448.68 $55,869 - $71,340	-159 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$372.64 - $458.3 $59,249 - $72,869	159 New	159 $66,000

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.21 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$1.01 Billion
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$745 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$424 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$386 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.

Account